This means a growth or tumor in the vagina. It's a general term for abnormal tissue changes, including cancer.
Every report comes from a Lived member, sent anonymously.
Have you tried Radiation Therapy for Vaginal Tumors?
Vaginal tumors are abnormal growths in the vagina, the muscular canal that runs from the cervix (the lower opening of the uterus) to the outside of the body. The term usually refers to vaginal cancer and to the precancerous changes that can come before it. Cancer that starts in the vagina is rare: it makes up only a small share of cancers of the female reproductive organs, and it is found most often in people in their 60s and older. Most vaginal cancers are squamous cell carcinomas, which begin in the thin, flat cells that line the vagina. They usually grow slowly, often over years, from abnormal but not yet cancerous cells called vaginal intraepithelial neoplasia (VaIN). Mild VaIN may clear on its own, while higher-grade VaIN is usually treated because it is closer to becoming cancer. About 1 in 10 vaginal cancers is an adenocarcinoma, which starts in gland cells and is somewhat more likely to spread. Melanoma and sarcoma of the vagina are much rarer and are managed differently. Cancer found in the vagina has more often started somewhere else, such as the cervix, uterus, rectum or bladder, and then spread. Those cancers are named and treated according to where they began. Early vaginal cancer often causes no symptoms and may first be noticed during a routine pelvic exam or Pap test. When symptoms do appear, the most common are bleeding or discharge not related to a period (including any bleeding after menopause), a lump in the vagina, pain during sex, pelvic pain, pain when urinating and constipation. These symptoms usually have other, more common causes, which is why they need an examination rather than guesswork.
Most vaginal cancers are linked to long-lasting infection with a high-risk type of human papillomavirus (HPV), the same virus behind most cervical cancers. HPV is very common and the immune system usually clears it; the risk comes from an infection that persists for years and gradually changes the cells lining the vagina. For the same reason, people who have had cervical precancer or cervical cancer have a higher chance of developing vaginal precancer or cancer. Other factors raise risk. Age matters most for squamous cell cancer, which is uncommon before 40. Smoking more than doubles the risk, and HIV (human immunodeficiency virus) makes it harder for the body to control HPV. A rare form called clear cell adenocarcinoma is linked to exposure before birth to diethylstilbestrol (DES), a hormone drug given to some pregnant women from the 1940s until 1971 to prevent miscarriage. Even among people exposed to DES, this cancer is very uncommon. Having a risk factor does not mean someone will develop vaginal cancer, and some people who develop it have no known risk factor. HPV vaccination may lower the risk of vaginal cancer, and it protects best when given before any exposure to the virus, ideally before someone becomes sexually active.
Evaluation usually starts with a pelvic exam. A clinician looks at the vagina and cervix with a speculum, feels the pelvic organs by hand and may check the rectum for lumps. A Pap test (a sample of surface cells) and an HPV test can show abnormal cells. Some cases of VaIN are found this way during routine cervical screening, and people whose cervix was removed because of cancer or precancer may have cells sampled from the upper vagina for the same purpose. If something looks abnormal, the next step is often colposcopy, in which a lighted magnifying instrument is used to examine the vagina and cervix closely. A biopsy, removing a small piece of tissue for a pathologist to examine under a microscope, is the only way to confirm cancer or VaIN and to tell which type it is. Once cancer is confirmed, staging shows how far it has spread, which shapes treatment. This may involve imaging such as magnetic resonance imaging (MRI), computed tomography (CT) or positron emission tomography (PET) scans and a chest X-ray, and sometimes cystoscopy or proctoscopy, which use a thin lighted tube to look inside the bladder or rectum. In stage I, cancer is confined to the vaginal wall. In stage II, it has grown into nearby tissue. In stage III, it reaches the wall of the pelvis. In stage IV, it has spread into the bladder or rectum, beyond the pelvis, or to distant organs such as the lungs or bones.
Treatment depends on the stage, the size and location of the tumor, its cell type, whether the uterus is still present and whether the pelvis has had radiation before. Because the vagina sits close to the bladder and rectum, care is usually planned by a gynecologic oncologist (a surgeon who specializes in cancers of the reproductive organs) together with a radiation oncologist. VaIN can often be treated with laser treatment that destroys the abnormal surface cells, removal of the affected area, medicine applied directly to the vagina, or internal radiation. Because new areas of abnormal cells can appear, follow-up continues afterward. Radiation is the most common treatment for invasive vaginal cancer. It usually combines external beam radiation, delivered by a machine over several weeks, with brachytherapy, in which a radiation source is placed inside the vagina for short sessions so that a high dose reaches the tumor while sparing more of the surrounding organs. For cancers that have grown beyond the vaginal wall (stages II to IVA), low-dose chemotherapy is often given at the same time to make radiation work better. This approach is borrowed from cervical cancer, and the evidence specific to vaginal cancer comes from small studies. Surgery suits some small cancers, particularly in the upper vagina. It may remove the tumor with a margin of healthy tissue, part or all of the vagina (vaginectomy), and nearby lymph nodes, sometimes with the uterus. The vagina can be rebuilt with tissue from elsewhere in the body. For some advanced or returning cancers, a much larger operation called pelvic exenteration removes the bladder, rectum and reproductive organs, and creates permanent openings for urine and stool. It is a major decision with lasting effects on daily life. When cancer has spread to distant organs, treatment focuses on controlling it and relieving symptoms. Radiation can ease pain and bleeding, and chemotherapy regimens used for cervical cancer are often tried, although no drug has been shown to help people with widespread vaginal cancer live longer. Because vaginal cancer is rare, clinical trials are a reasonable option to ask about at any stage.
Outlook depends mostly on how far the cancer has spread when it is found. Based on US data for people diagnosed from 2015 to 2021, about 76% of those whose cancer was confined to the vaginal wall were alive five years later, compared with people of the same age without the cancer. That figure was about 59% when it had reached nearby tissue or lymph nodes, and about 24% when it had spread to distant organs. These are averages from past patients and cannot predict any one person's course. Radiation brings short-term effects such as tiredness, diarrhea, nausea, bladder irritation and sore, tender skin in the treated area, which are usually worse when chemotherapy is given at the same time and ease in the weeks after treatment ends. Some effects last. Pelvic radiation often causes early menopause in people who have not yet reached it, and it can leave bowel or bladder irritation that persists or appears months later. Radiation also tends to scar the vagina, making it shorter, narrower and drier. This can make sex painful and pelvic exams difficult. Regularly stretching the vagina, usually with a dilator (a smooth tube used for a few minutes several times a week), helps prevent narrowing, and vaginal moisturizers or creams help with dryness. Keeping the vagina open matters even for people who are not sexually active, because follow-up depends on being able to examine it comfortably. After treatment, follow-up visits are frequent at first and become less frequent over time. They usually include pelvic exams and Pap tests, and sometimes colposcopy or scans, to check for cancer coming back and for late effects. Changes in body image, sexuality and mood are common after this cancer, and many cancer centers offer sexual health counseling, pelvic floor therapy and support groups.
Make an appointment for a pelvic exam if you notice vaginal bleeding that is not part of a normal period (especially any bleeding after menopause), unusual discharge, a lump in the vagina, pain during sex or ongoing pelvic pain. These are more often caused by something other than cancer, but they should be checked rather than waited out. Keep up with cervical screening, and if you have had cervical precancer or cancer, or were exposed to DES before birth, ask how often you need checks. During or after treatment, contact your care team promptly about heavy or increasing vaginal bleeding, bloody stools, persistent diarrhea, painful or frequent urination, or urine, stool or gas leaking from the vagina, which can signal an abnormal connection between organs after radiation. Also report any new lump, pain or bleeding at follow-up, since these can be the first signs that cancer has returned.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Vaginal Tumors is like, what's helped you, or ask the community a question.